Works by Zerbini, Cristiano A. F.


Results: 21
    1
    2
    3

    Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020).

    Published in:
    Archives of Osteoporosis, 2021, v. 16, n. 1, p. 1, doi. 10.1007/s11657-021-00902-z
    By:
    • Pereira, Rosa M. R.;
    • Perez, Mariana O.;
    • Paula, Ana Patrícia;
    • Moreira, Caio;
    • Castro, Charlles H. M.;
    • Zerbini, Cristiano A. F.;
    • Domiciano, Diogo S.;
    • de Azevedo, Elaine;
    • Mendonca, Laura M. C.;
    • Shinzato, Marcia Midore;
    • da Rocha-Loures, Marco Antonio A.;
    • Radominski, Sebastião;
    • Szejnfeld, Vera L.
    Publication type:
    Article
    4
    5

    Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.

    Published in:
    Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1410-1
    By:
    • Schiff, Michael;
    • Tsutomu Takeuchi;
    • Fleischmann, Roy;
    • Gaich, Carol L.;
    • DeLozier, Amy M.;
    • Schlichting, Douglas;
    • Wen-Ling Kuo;
    • Ji-Eon Won;
    • Carmack, Tara;
    • Rooney, Terence;
    • Durez, Patrick;
    • Shaikh, Saeed;
    • Hidalgo, Rodolfo Pardo;
    • van Vollenhoven, Ronald;
    • Zerbini, Cristiano A. F.
    Publication type:
    Article
    6
    7
    8
    9

    Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.

    Published in:
    Archives of Osteoporosis, 2019, v. 14, n. 1, p. 1, doi. 10.1007/s11657-019-0561-x
    By:
    • Minisola, Salvatore;
    • Marin, Fernando;
    • Kendler, David L.;
    • Geusens, Piet;
    • Zerbini, Cristiano A. F.;
    • Russo, Luis A.;
    • Casado, Enrique;
    • Fahrleitner-Pammer, Astrid;
    • Stepan, Jan J.;
    • Lespessailles, Eric;
    • Moericke, Rüdiger;
    • Bagur, Alicia;
    • Lakatos, Péter;
    • López-Romero, Pedro;
    • Body, Jean Jacques
    Publication type:
    Article
    10

    Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.

    Published in:
    Journal of Bone & Mineral Research, 2018, v. 33, n. 5, p. 783, doi. 10.1002/jbmr.3384
    By:
    • Geusens, Piet;
    • Marin, Fernando;
    • Kendler, David L.;
    • Russo, Luis A.;
    • Zerbini, Cristiano A. F.;
    • Minisola, Salvatore;
    • Body, Jean Jacques;
    • Lespessailles, Eric;
    • Greenspan, Susan L.;
    • Bagur, Alicia;
    • Stepan, Jan J.;
    • Lakatos, Péter;
    • Casado, Enrique;
    • Moericke, Rüdiger;
    • López‐Romero, Pedro;
    • Fahrleitner‐Pammer, Astrid
    Publication type:
    Article
    11
    12

    Efficacy and Safety of Long‐Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate

    Published in:
    2020
    By:
    • Fleischmann, Roy;
    • Takeuchi, Tsutomu;
    • Schiff, Michael;
    • Schlichting, Douglas;
    • Xie, Li;
    • Issa, Maher;
    • Stoykov, Ivaylo;
    • Lisse, Jeffrey;
    • Martinez‐Osuna, Pindaro;
    • Rooney, Terence;
    • Zerbini, Cristiano A. F.;
    • Martinez-Osuna, Pindaro
    Publication type:
    journal article
    13
    14

    Patient and Physician Expectations of Add-On Treatment With Golimumab for Rheumatoid Arthritis: Relationships Between Expectations and Clinical and Quality of Life Outcomes.

    Published in:
    Arthritis Care & Research, 2014, v. 66, n. 12, p. 1799, doi. 10.1002/acr.22371
    By:
    • Dasgupta, Bhaskar;
    • Combe, Bernard;
    • Louw, Ingrid;
    • Wollenhaupt, Jürgen;
    • Zerbini, Cristiano A. F.;
    • Beaulieu, Andre;
    • Schulze-Koops, Hendrik;
    • Durez, Patrick;
    • Wolff, Verónica;
    • Yao, Ruji;
    • Weng, Haoling H.;
    • Govoni, Marinella;
    • Vastesaeger, Nathan
    Publication type:
    Article
    15
    16
    17

    Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.

    Published in:
    Rheumatology, 2016, v. 55, n. 8, p. 1466, doi. 10.1093/rheumatology/kew179
    By:
    • Vastesaeger, Nathan;
    • Garcia Kutzbach, Abraham;
    • Amital, Howard;
    • Pavelka, Karel;
    • Lazaro, María Alicia;
    • Moots, Robert J.;
    • Wollenhaupt, Jürgen;
    • Zerbini, Cristiano A. F.;
    • Louw, Ingrid;
    • Combe, Bernard;
    • Beaulieu, Andre;
    • Schulze-Koops, Hendrik;
    • Dasgupta, Bhaskar;
    • Bo Fu;
    • Huyck, Susan;
    • Haoling H. Weng;
    • Govoni, Marinella;
    • Durez, Patrick
    Publication type:
    Article
    18

    Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study.

    Published in:
    Arthritis & Rheumatology, 2019, v. 71, n. 6, p. 878, doi. 10.1002/art.40803
    By:
    • Heijde, Désirée;
    • Strand, Vibeke;
    • Tanaka, Yoshiya;
    • Keystone, Edward;
    • Kremer, Joel;
    • Zerbini, Cristiano A. F.;
    • Cardiel, Mario H.;
    • Cohen, Stanley;
    • Nash, Peter;
    • Song, Yeong‐Wook;
    • Tegzová, Dana;
    • Gruben, David;
    • Wallenstein, Gene;
    • Connell, Carol A.;
    • Fleischmann, Roy;
    • Hall, Stephen;
    • Nicholls, David;
    • Rischmueller, Maureen;
    • Baker, Milton F.;
    • Bessette, Louis
    Publication type:
    Article
    19

    Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment.

    Published in:
    Arthritis & Rheumatology, 2017, v. 69, n. 3, p. 506, doi. 10.1002/art.39953
    By:
    • Fleischmann, Roy;
    • Schiff, Michael;
    • van der Heijde, Désirée;
    • Ramos‐Remus, Cesar;
    • Spindler, Alberto;
    • Stanislav, Marina;
    • Zerbini, Cristiano A. F.;
    • Gurbuz, Sirel;
    • Dickson, Christina;
    • de Bono, Stephanie;
    • Schlichting, Douglas;
    • Beattie, Scott;
    • Kuo, Wen‐Ling;
    • Rooney, Terence;
    • Macias, William;
    • Takeuchi, Tsutomu
    Publication type:
    Article
    20

    Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study

    Published in:
    Therapeutic Advances in Musculoskeletal Disease, 2021, p. 1, doi. 10.1177/1759720X211006964
    By:
    • Yang, Yue;
    • Xu, Jianhua;
    • Xu, Jian;
    • Li, Xingfu;
    • Hu, Jiankang;
    • Li, Xiangpei;
    • Zhang, Xiao;
    • He, Dongyi;
    • Bao, Chunde;
    • Li, Zhijun;
    • Wang, Guochun;
    • Zerbini, Cristiano A. F.;
    • Spindler, Alberto J.;
    • Kannowski, Carol L.;
    • Wu, Hanjun;
    • Ji, Fei;
    • Zhan, Lujing;
    • Liu, Mengru;
    • Li, Zhanguo
    Publication type:
    Article
    21

    Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study

    Published in:
    Therapeutic Advances in Musculoskeletal Disease, 2021, p. 1, doi. 10.1177/1759720X211006964
    By:
    • Yang, Yue;
    • Xu, Jianhua;
    • Xu, Jian;
    • Li, Xingfu;
    • Hu, Jiankang;
    • Li, Xiangpei;
    • Zhang, Xiao;
    • He, Dongyi;
    • Bao, Chunde;
    • Li, Zhijun;
    • Wang, Guochun;
    • Zerbini, Cristiano A. F.;
    • Spindler, Alberto J.;
    • Kannowski, Carol L.;
    • Wu, Hanjun;
    • Ji, Fei;
    • Zhan, Lujing;
    • Liu, Mengru;
    • Li, Zhanguo
    Publication type:
    Article